Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiu-wei-zhen-xiao Granule in Advanced HCC
NCT03851471Phase 1Completed
- Start
- Apr 2019
- Primary completion
- Jul 2020
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Jiu-wei-zhen-xiao in hepatocellular carcinoma (HCC). Primary endpoint: Overall Survival at 12 weeks. Started Apr 2019; status: completed.
02
Drugs
Jiu-wei-zhen-xiao
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03851471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03851471.